See also this year's filing and all EDGAR filings for this company.
PDF Report 0000810509_2015_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000810509')"} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 3,089,420 |
| 1 | LiabilitiesCurrent | 9,095,091 |
| 2 | remainder_Liabilities | 29,539,135 |
| 3 | AssetsCurrent | 8,599,145 |
| 4 | AssetsNoncurrent | 388,919 |
| 5 | PropertyPlantAndEquipmentNet | 2,509,708 |
| 6 | Goodwill | 180,833 |
| 7 | remainder_Assets | 241,575 |
| 8 | GeneralAndAdministrativeExpense | 15,542,071 |
| 9 | ResearchAndDevelopmentExpense | 16,779,589 |
| 10 | remainder_Expenses | 1,586,145 |
| 11 | remainder_Revenues | 6,274,849 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 41,723,646 |
| 1 | Assets | 11,920,180 |
| 2 | Expenses | 33,907,805 |
| 3 | Revenues | 6,274,849 |
| 4 | StockholdersEquity | -29,803,466 |
| 5 | NetIncome | -27,632,956 |
| 6 | ComprehensiveNetIncome | -27,632,956 |
| 7 | BaseVar | 46,913,240 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.55 |
| 9 | EconomicCapitalRatio | 0.199 |
Edgar->Model Mapping
Feature Distribution
Change over Time
